Workforce Development & LeadershipIDEAYA Appoints Joshua Bleharski as CFOPR NewswireFebruary 10, 2025August 1, 2025 by PR NewswireFebruary 10, 2025August 1, 20250100 IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, today announced the appointment of Joshua Bleharski, Ph.D....
